Nephrotic syndrome - Clinical Features and Evaluation

Nephrotic Syndrome: A Comprehensive Overview Introduction Nephrotic syndrome is a clinical condition characterized by severe proteinuria, hypoalbuminemia, edema, and hyperlipidemia. It represents a spectrum of glomerular diseases that damage the filtration barrier of the kidney, allowing large amounts of protein to escape into the urine. Understanding nephrotic syndrome requires knowledge of its epidemiology, clinical features, complications, and how to diagnose it accurately. Epidemiology: Who Gets Nephrotic Syndrome? The specific glomerular diseases that cause nephrotic syndrome vary significantly based on age and sex. Age Distribution The most common cause of nephrotic syndrome differs dramatically between children and adults. In children, minimal change disease is overwhelmingly the most frequent, accounting for approximately 66% of all glomerular disease cases. This is important because it means pediatric patients with nephrotic syndrome are likely to respond well to corticosteroid therapy, which is the first-line treatment for minimal change disease. In contrast, adults present with a different disease pattern. Mesangiocapillary glomerulonephritis becomes the most common primary cause in adults, representing 30–40% of cases. This shift in disease prevalence between age groups has significant implications for prognosis and treatment decisions. Primary versus Secondary Nephrotic Syndrome When evaluating nephrotic syndrome, clinicians must distinguish between primary (idiopathic) and secondary forms. Approximately 60–80% of glomerulonephritis cases are primary, meaning the kidney disease is the main problem itself. The remaining 20–40% are secondary, arising from underlying systemic diseases such as diabetes mellitus, systemic lupus erythematosus, or infections. This distinction fundamentally changes the diagnostic approach and treatment strategy. <extrainfo> Sex Differences Men are affected twice as often as women, with a male-to-female ratio of 2:1. While this is clinically notable, the reason for this difference remains incompletely understood. </extrainfo> Clinical Presentation: The Four Hallmarks of Nephrotic Syndrome Nephrotic syndrome presents with four characteristic features that result from damage to the glomerular filtration barrier. Understanding the mechanisms behind each feature is crucial for comprehending the disease. Proteinuria: Massive Protein Loss The hallmark finding in nephrotic syndrome is heavy proteinuria—protein loss exceeding $3.5\ \text{g}$ per $1.73\ \text{m}^2$ of body surface area per day. To put this in perspective, normal protein excretion is less than 150 mg per day, so nephrotic-range proteinuria represents more than a 20-fold increase. When urine is examined clinically, this massive proteinuria manifests as foamy urine, caused by the high protein concentration creating surface tension and bubble formation. The traditional urine dipstick or microscopy examination will typically show heavy proteinuria but notably lacks red blood cells or casts—this absence of hematuria helps distinguish nephrotic syndrome from glomerulonephritis, which often presents with a more active urinary sediment. The protein-to-creatinine ratio in nephrotic syndrome is greater than $200–400\ \text{mg/mmol}$, which can be measured in a spot urine sample when 24-hour collection is impractical. Hypoalbuminemia: Low Blood Protein As massive amounts of protein are lost in the urine, serum albumin concentration falls below $2.5\ \text{g/dL}$. This drop occurs because the liver cannot synthesize enough albumin to replace urinary losses. The loss of this critical protein has cascading consequences throughout the body, leading to many of the clinical manifestations of nephrotic syndrome. Hyperlipidemia: Elevated Blood Lipids Patients develop elevated blood levels of low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL), resulting in hyperlipidemia. The mechanism behind this lipid abnormality involves increased hepatic synthesis of lipoproteins in response to the loss of circulating proteins and alterations in lipid metabolism related to hypoalbuminemia. Edema: Fluid Accumulation Edema is perhaps the most visible clinical manifestation of nephrotic syndrome. Patients present with various types of fluid accumulation: Periorbital edema (puffiness around the eyes, often worst in the morning) Pitting edema of the legs and dependent areas Pleural effusion (fluid around the lungs) Pulmonary edema (fluid within lung tissue) Ascites (fluid in the abdominal cavity) Generalized anasarca (widespread body swelling) Understanding Edema Formation: Two Competing Hypotheses The mechanism of edema formation in nephrotic syndrome has been debated for decades, and modern understanding suggests both mechanisms operate: The Underfill Hypothesis: The primary driver is the severe hypoalbuminemia. Albumin is the major protein responsible for maintaining oncotic (colloid osmotic) pressure in the blood. With albumin levels plummeting, the blood cannot retain fluid, which leaks into tissue spaces. Simultaneously, reduced plasma volume activates compensatory mechanisms including the renin-angiotensin-aldosterone system (RAAS), which promotes sodium and water retention by the kidneys—attempting to restore intravascular volume. The Overfill Hypothesis: In addition to protein loss, there is inappropriate sodium and water retention by the kidneys themselves. This occurs through activation of the epithelial sodium channel (ENaC) in the collecting duct, leading to primary fluid retention and volume expansion. This excess fluid accumulates in tissue spaces as edema. Both mechanisms likely contribute simultaneously in nephrotic syndrome, and their relative importance may vary between patients. The key clinical insight is that reducing proteinuria (through ACE inhibitors, ARBs, or specific glomerular disease treatments) and restricting sodium intake can both help resolve edema by addressing both mechanisms. Complications: Why Nephrotic Syndrome Is Dangerous Nephrotic syndrome carries significant morbidity and mortality risk due to several serious complications that develop from the changes in blood composition and kidney function. Thromboembolic Disorders (Hypercoagulability) One of the most serious complications is a dramatically increased risk of blood clots (thromboembolism), particularly in the renal veins. The mechanism involves loss of antithrombin III in the urine. Antithrombin III is a natural anticoagulant protein that normally prevents inappropriate clotting. When it is filtered and excreted in large quantities, blood becomes hypercoagulable (prone to clotting). Additionally, other protective proteins may be lost, while clotting factors are relatively preserved or even increased in response to protein losses. This hypercoagulable state is particularly dangerous and can lead to renal vein thrombosis, deep vein thrombosis, pulmonary embolism, and cerebral venous thrombosis—all of which can be life-threatening. Infections The loss of immunoglobulins and other immune-related proteins in the urine predisposes patients to serious infections including: Peritonitis (peritoneal inflammation, especially from streptococcal species) Pneumonia Skin and soft tissue infections Urinary tract infections Meningitis Septicemia This immunological vulnerability is particularly problematic in children with minimal change disease and represents a major cause of morbidity in nephrotic syndrome. Acute Kidney Injury Severe nephrotic syndrome can paradoxically cause acute kidney failure despite the kidneys being the source of the problem. The mechanism involves massive sequestration of fluid in the interstitium and tissue spaces. This reduces the effective circulating blood volume (hypovolemia), leading to inadequate renal perfusion pressure. The kidneys respond as if the body is volume-depleted, further activating the RAAS and promoting sodium retention. If this becomes severe enough, acute tubular necrosis can develop, causing acute kidney injury. Pulmonary Edema The reduced plasma oncotic pressure from severe hypoalbuminemia allows fluid to accumulate not only in tissue spaces but also within the lungs themselves. Pulmonary edema causes dyspnea (shortness of breath), orthopnea (difficulty breathing when lying flat), and hypoxemia. In severe cases, this can progress to respiratory failure. <extrainfo> Nutritional and Growth Effects The massive protein losses exceed what many patients can consume, creating a negative nitrogen balance and resulting in protein malnutrition. In children, this protein deficiency, combined with reduced appetite and the metabolic effects of prolonged corticosteroid therapy, can cause growth retardation and developmental delays. </extrainfo> Diagnosis: Identifying Nephrotic Syndrome Diagnosis of nephrotic syndrome combines clinical findings with laboratory and imaging studies to both confirm the diagnosis and identify the underlying cause. Urine Testing Dipstick and Microscopy: A urine dipstick will reveal heavy proteinuria, and microscopic examination shows the characteristic finding of foamy urine. Notably, the urine typically lacks red blood cells (RBCs) and casts, which helps distinguish nephrotic-range proteinuria from nephritic proteinuria (which has active urinary sediment). 24-hour Urine Protein: This remains the gold standard for quantifying proteinuria and is essential for diagnosis and monitoring treatment response. A value exceeding $3.5\ \text{g}$ per $1.73\ \text{m}^2$ per day confirms nephrotic-range proteinuria. Spot Urine Protein-to-Creatinine Ratio: As an alternative to 24-hour collection, a spot urine sample with a protein-to-creatinine ratio greater than $200–400\ \text{mg/mmol}$ strongly suggests nephrotic syndrome and is more practical in many settings. Blood Laboratory Tests Kidney Function: Creatinine clearance or estimated glomerular filtration rate (eGFR) assesses overall kidney function and helps determine disease severity. Many patients with nephrotic syndrome have normal or near-normal kidney function at presentation, though this can deteriorate over time. Serum Albumin: A serum albumin concentration below $2.5\ \text{g/dL}$ confirms the hypoalbuminemia component of nephrotic syndrome. Lipid Panel: Elevated LDL and VLDL confirm hyperlipidemia and have prognostic significance. Imaging Renal Ultrasound: Ultrasound evaluates kidney size and structure, helping identify whether both kidneys are affected (suggesting primary glomerulonephritis) or if there are other structural abnormalities suggesting secondary causes or chronic disease. Kidney Biopsy and Pathology When to Biopsy: Kidney biopsy is the gold standard for determining the specific histological diagnosis but carries some risk, so it is reserved for: Adults with suspected nephrotic syndrome (because treatment decisions differ based on histology) Children who do not respond to initial corticosteroid therapy (steroid-resistant nephrotic syndrome) Children presenting with features atypical for minimal change disease When kidney tissue is examined microscopically, different glomerular diseases show characteristic patterns of damage. The images below show examples of different pathological findings: Serological Testing for Secondary Causes Autoimmune Serologies: When clinical or laboratory features suggest a secondary systemic disease (such as lupus, vasculitis, or other autoimmune conditions), specific antibody testing is essential: Antinuclear antibody (ANA) for lupus Complement levels (C3, C4) for lupus and other immune complex diseases ANCA (antineutrophil cytoplasmic antibodies) for vasculitis Anti-GBM antibodies for Goodpasture syndrome These tests help identify secondary nephrotic syndrome and guide appropriate systemic treatment. Differential Diagnosis: What Else Could This Be? Nephrotic syndrome can be mimicked by other conditions, so careful differential diagnosis is essential. Edema Mimics Other serious conditions also cause generalized edema and must be distinguished from nephrotic syndrome: Congestive Heart Failure: Decreased cardiac output reduces renal perfusion, activating sodium retention mechanisms and causing edema. However, cardiac imaging (echocardiography) will show ventricular dysfunction, and the patient may have orthopnea, elevated jugular venous pressure, and cardiac murmurs. Liver Cirrhosis: Advanced liver disease causes hypoalbuminemia (from decreased synthesis), portal hypertension, and edema/ascites. Key distinguishing features include abnormal liver function tests, elevated bilirubin, coagulopathy, and often a history of liver disease. In contrast, patients with nephrotic syndrome typically have normal or near-normal kidney function initially, normal liver function tests, and normal coagulation studies. Proteinuria from Other Sources Other conditions can produce proteinuria without the full nephrotic syndrome picture, particularly without hypoalbuminemia: Multiple Myeloma: Produces monoclonal immunoglobulin that appears as proteinuria on dipstick. However, serum protein electrophoresis shows a distinctive M-spike, and the patient typically has hypercalcemia, anemia, and lytic bone lesions. Diabetes Mellitus: Can cause heavy proteinuria and nephrotic syndrome, but this is considered secondary nephrotic syndrome. Key features include a history of diabetes, diabetic retinopathy, and evidence of diabetic nephropathy on kidney biopsy. Amyloidosis: Produces proteinuria that can be nephrotic in range. Differentiation requires tissue biopsy showing Congo red-positive deposits and often involves multisystem findings (neuropathy, cardiomyopathy). Medication-Induced Edema Several medications cause peripheral edema and fluid retention that can resemble nephrotic syndrome: Non-steroidal anti-inflammatory drugs (NSAIDs): Inhibit prostaglandin synthesis, reducing natriuresis and causing fluid retention and edema Certain antihypertensives: Calcium channel blockers can cause peripheral edema through arteriolar vasodilation Corticosteroids: Cause sodium retention and weight gain from fluid accumulation Sex hormones: Oral contraceptives and hormone replacement therapy cause fluid retention A careful medication history is essential, and edema often resolves after discontinuing the offending agent. These conditions will not show the characteristic combination of heavy proteinuria, hypoalbuminemia, and hyperlipidemia seen in nephrotic syndrome.